As a multi-stage VC fund, Lightspeed has an advantage in its exposure to both early-stage and later-stage healthcare markets, Imanbayev said.
And many later-stage healthcare startups still have plenty of room to grow, he said.
The first one to three years are often slow-moving for a healthcare startup, too, as it works to get its first partnerships with payers or providers, he said.
But they also tend to be less risky, since later-stage startups should have revenue streams or partnerships that demonstrate their value.
Lightspeed led value-based care startup Aledade's $260 million Series F in June 2023, an unusually large deal as other investors cut much smaller checks.
Persons:
—, Galym, Imanbayev, I'm, There's, Farzad Mostashari, Aledade Tom Sandner, VCs, Abridge, he's, Chris Severn
Organizations:
Business, Lightspeed Venture Partners, Lightspeed, CVS, Health, Turquoise Health, Pharma, FDA, pharma